Thornberry Nancy
- SEC CIK
- 0001797826
In the past year, 1 open-market sale filing worth $261.9K and no purchases.
Current role at each company
- DNLI Denali Therapeutics Inc.Directoras of Sep 4, 2026
- SDGR Schrodinger, Inc.Directoras of Jun 23, 2026
- VRTX Vertex Pharmaceuticals IncDirectoras of May 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $261.9K
- 1 filing
- Net
- −$261.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Thornberry Nancy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DNLI Denali Therapeutics Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 (view filing)5:02 PM ET | Sep 2 | 2 days | Thornberry NancyDirector | SSale | −11.4K | $22.90 | −$261.9K | −36.8%19.7K after | 2 lots10b5-1 |
SDGR Schrodinger, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 (view filing) | May 22 | 1 day | Thornberry NancyDirector | SSale | −14.8K | $35.00 | −$519.8K | −100.0%0 after | |
| Aug 12, 2022 (view filing) | Aug 11 | 1 day | Thornberry NancyDirector | SSale | −4.95K | $35.00 | −$173.3K | −100.0%0 after |